TMTP1‐Modified Small Extracellular Vesicles Target BRAF Mutation in Anaplastic Thyroid Cancer Reversing Vemurafenib Resistance With CRISPR/Cas9 Delivery

Shuo Zhang(First Hospital of China Medical University)
Journal of Extracellular Vesicles
September 1, 2025
Cited by 1


Related Papers